Develops generic drugs for high-incidence diseases in China.
Jun 2026Revenue $3.91M/yrExpenses $8.29M/yr
No trendCash runway ≈ 2.2 years from Jun 2026
Figures by year
When will China Pharma Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $3.91M and expenses $8.29M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.14M | $7.38M | −$3.24M |
| Dec 2024 | $4.53M | $9.12M | −$4.59M |
| Dec 2023 | $7.01M | $9.76M | −$2.75M |
| Dec 2022 | $8.10M | $11.7M | −$3.55M |
| Dec 2021 | $9.64M | $12.5M | −$2.86M |
| Dec 2020 | $10.9M | $13.4M | −$2.58M |
| Dec 2019 | $10.9M | $31.3M | −$20.4M |
| Dec 2018 | $12.3M | $22.8M | −$10.4M |
| Dec 2017 | $13.2M | $31.9M | −$18.7M |
| Dec 2016 | $15.6M | $23.7M | −$8.16M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.